- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.40 Å
- Oligo State
- homo-trimer
- Ligands
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NDG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-alpha-D-glucopyranose(Non-covalent)
- 25 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.12: 3 residues within 4Å:- Chain A: T.94, N.220, T.222
Ligand excluded by PLIPNAG.13: 1 residues within 4Å:- Chain A: N.1117
Ligand excluded by PLIPNAG.14: 1 residues within 4Å:- Chain A: N.692
Ligand excluded by PLIPNAG.15: 2 residues within 4Å:- Chain A: N.784, S.786
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain A: Y.14, N.47
Ligand excluded by PLIPNAG.17: 2 residues within 4Å:- Chain A: N.317, Q.566
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain A: A.689, N.1057
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain A: N.1081, T.1083, F.1086
Ligand excluded by PLIPNAG.20: 1 residues within 4Å:- Chain A: N.268
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain A: N.602, T.604
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain B: T.94, N.220
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain B: N.602, T.604, Q.630
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain B: N.692, I.1113
- Chain C: D.779
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain B: N.1081, H.1084, F.1086
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain B: N.150, N.151
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain A: K.544
- Chain B: N.266, N.268
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain B: H.641, N.643
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain B: N.1057
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain C: C.1065, C.1109, N.1117
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain C: N.1081, T.1083, H.1084, F.1086
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain C: A.689, E.1055, N.1057
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain A: D.779
- Chain C: N.692, G.1114
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain C: N.784, S.786
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain C: N.602
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain C: N.317, P.565, Q.566
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ginex, T. et al., The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation. Plos Pathog. (2022)
- Release Date
- 2022-05-25
- Peptides
- Spike glycoprotein,Fibritin: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.40 Å
- Oligo State
- homo-trimer
- Ligands
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NDG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-alpha-D-glucopyranose(Non-covalent)
- 25 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ginex, T. et al., The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation. Plos Pathog. (2022)
- Release Date
- 2022-05-25
- Peptides
- Spike glycoprotein,Fibritin: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C